Synergia Life Sciences

What Synergia Life Sciences does

Synergia Life Sciences is a privately held Mumbai-based manufacturer operating in the chemicals, pharmaceuticals, and botanical products sectors. Founded in 2004, the company employs between 101 and 250 people and operates from India as a for-profit entity. Its short-description scope covers three adjacent product categories — industrial/specialty chemicals, pharmaceutical manufacturing, and botanical (plant-derived) products — indicating a diversified manufacturer rather than a single-vertical producer.

The company's stated offerings span chemicals and chemical products, pharmaceuticals, and botanical products, suggesting it produces formulated or extracted goods across these categories. No specific product catalog, formulation details, manufacturing process, technical platform, certifications (e.g., GMP, ISO), or patent portfolio is disclosed in the available data, limiting deeper technical assessment. The leadership team is director-heavy and includes overlapping financial roles: Ashit Harshad Vora and Vishal Vora are both associated with the CFO function, while Harshad Chhotalal Vora, Anirudh Dilip Mehta, Anslem Julius Desouza, and Dilip Sukhlal Mehta serve as directors — a governance structure that suggests family-linked ownership or promoter control typical of Indian mid-market manufacturers.

Commercially, Synergia Life Sciences received a single disclosed growth-stage funding round of approximately $6.1M in October 2015, led by InvAscent, an India-focused mid-market private equity firm. No pricing model, customer segments, distribution channels, go-to-market motion, named customer logos, geographic footprint beyond India, or recurring/repeat capital events are documented in the input material. The company website (synergialifesciences.com) is the only confirmed first-party digital presence. As a result, the business model is best characterized as B2B manufacturing sales to industrial, pharmaceutical, and botanical-product buyers, but specific revenue mechanics, contract structures, and end-market mix cannot be confirmed from the data provided.

Name

Synergia Life Sciences

Website

https://synergialifesciences.com

Company type

Private

Founded year

2004

Headcount range

101–250 employees

Short description

Synergia Life Sciences is a Mumbai-based, privately held manufacturer of chemicals, pharmaceuticals, and botanical products founded in 2004, serving industrial and healthcare customers with a workforce of 101–250.

Ownership category

akta.pro rank

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Core offering

Synergia Life Sciences manufactures chemicals, chemical products, pharmaceuticals, and botanical products. The company produces physical goods used as inputs by downstream pharmaceutical, nutraceutical, and chemical industry buyers. Operations are based in Mumbai, India, and the firm was founded in 2004.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Granules India: Indian manufacturer of APIs, pharmaceutical intermediates, and finished dosages with global customers. Similar specialty manufacturing focus and exposure to international regulated markets.
• Divi's Laboratories: Indian manufacturer of active pharmaceutical ingredients (APIs), intermediates, and nutraceutical/botanical ingredients with significant export exposure. Highly comparable to Synergia in being an Indian, chemistry-led, multi-vertical manufacturer serving global pharma customers, though at much larger scale.
• Laurus Labs: Indian manufacturer of APIs, intermediates, and finished dosage forms with a strong focus on specialty ingredients. Direct comparator in scale, geography, and the chemistry-driven, multi-product manufacturing model.
• Indoco Remedies: Mid-sized Indian manufacturer of APIs and formulations with domestic and export presence. Closely comparable mid-tier Indian pharma manufacturer profile with multi-vertical exposure.
• Suven Pharmaceuticals: Indian CDMO and API manufacturer focused on niche, complex molecules for global pharma. Comparable to Synergia in business model (specialty manufacturing for global customers) and product mix (intermediates, APIs, fine chemicals).

Broad incumbents

• Piramal Pharma Solutions: Indian-headquartered pharma CDMO offering APIs, drug products, and biologics services globally. Comparable manufacturing capabilities and customer base, though materially larger and broader in scope.
• Aurobindo Pharma: One of India's largest vertically integrated pharmaceutical manufacturers with APIs, formulations, and specialty products. Overlapping with Synergia's chemistry/pharma manufacturing footprint but at far greater scale and global reach.
• Syngene International: Indian CRO/CDMO offering discovery, development, and manufacturing services to global pharma. Comparable Indian contract scientific services / manufacturing model serving global life sciences customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/synergialifesciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synergia Life Sciences